Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer

Table 4

Correlation of CXC chemokine gene expression and clinical characteristics of patients with colon cancer in TCGA.

Gene		Sex (female)	Group stage (III+IV)	T stage T3+T4	N stage (N1+N2)	M stage (yes)	P53 (mutant)
CXCL1	0.100^0.038		-0.126^0.010		-0.117^0.016
CXCL2	0.097^0.044		-0.115^0.018		-0.121^0.012
CXCL3	0.117^0.015		-0.141^0.004		-0.136^0.005	-0.120^0.020
CXCL4
CXCL5
CXCL6
CXCL7
CXCL8
CXCL9	0.099^0.040		-0.179^0.000		-0.145^0.003	-0.175^0.001
CXCL10			-0.154^0.002		-0.133^0.006	-0.146^0.004
CXCL11			-0.150^0.002		-0.142^0.003	-0.125^0.015
CXCL12
CXCL13
CXCL14
CXCL16		0.119^0.014
CXCL17

Correlation with value < 0.05; Correlation with value < 0.01.